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Abstract
Background: Intellectual disability (ID) is a serious disorder of the central nervous system with a prevalence of 1-
3% in a general population. In the past decades, the research focus has been predominantly on X-linked ID (68 loci
and 19 genes for non syndromic X linked ID) while for autosomal recessive nonsyndromic ID (NSID) only 30 loci
and 6 genes have been reported to date.
Methods: Genome-wide homozygosity mapping with 500 K Nsp1 array (Affymetrix), CNV analysis, PCR based
breakpoint mapping and DNA sequencing was performed to explore the genetic basis of autosomal recessive
nonsyndromic ID in a large Pakistani family.
Results: Data analysis showed linkage at 8p23 locus with common homozygous region between SNPs rs6989820
and rs2237834, spanning a region of 12.494 Mb. The subsequent CNV analysis of the data revealed a homozygous
deletion of 170.673 Kb which encompassed the TUSC3 gene.
Conclusion: We report a novel deletion mutation in TUSC3 gene which is the second gene after TRAPPC9 in which
mutation has been identified in more than one family with autosomal recessive NSID. The study will aid in
exploring the molecular pathway of cognition.
Background
Intellectual disability (ID), also frequently referred to as
Mental Retardation or cognitive impairment (CI), is a
condition where intelligence quotient is less than 70,
there is deficiency in at least two adaptive skills like
communication, reading, writing, self care etc and onset
before 18 year of age [1]. Assuming a population mean
IQ of 100, ID is subcategorized as mild (50-55 to 70),
moderate (35-40 to 50-55), severe (20-25 to 35-40) and
profound (below 20-25) [1,2].
G e n e r a l l yi ti sb e l i e v e dt h a t~ 2 5 %o fg e n e t i cI D
patients are thought to have autosomal recessive mode
of inheritance [3]. To date 30 loci including six known
genes have been reported to be involved in autosomal
recessive NS-ID (ARNS-ID) [4]. These include PRSS12
(Protease, Serine, 12 or Neurotrypsin; MIM# 606709)
[5], CRBN (Cereblon; MIM# 609262) [6], CC2D1A
(Coiled-coil and C2 domain containing protein 1A;
MIM# 610055) [7], GRIK2 (Glutamate receptor, ionotro-
pic, kainite 2; MIM#138244) [8], TUSC3 (Tumor sup-
pressor candidate 3; MIM# 601385) [9,10], TRAPPC9
(Trafficking protein particle complex subunit 9; MIM#
611966) [11-13].
Chromosome 8 is considered an average chromosome
with respect to size (146.364 Mb), number of genes
(1198), repeat content and degree of segmental duplica-
tion [14]. But its p arm showed high degree of sequence
variations, particularly within its distal-most ~15 mega-
base region. This region is believed to be of prime
importance in the human genome because of the high
expression pattern of nervous system related genes, and
has recently been touted as a “hub” for neuropsychiatric
developmental disorders [15]. Many genomic imbalances
on 8p locus, such as duplication of 8p23.1-8p22.2, are
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for microcephaly (MCPH1)a n do n eg e n ef o rN S - I D ,
namely TUSC3, have been identified on 8p.
In this study we present the clinical and molecular
analysis of a consanguineous Pakistani family with auto-
somal recessive NS-ID, and report a novel mutation
comprising deletion of the entire TUSC3 gene (except
for the promoter and 1
st exon) and its down stream
region at the 8p23 locus.
Methods
A: Sampling and DNA extraction
The family was recruited from a rural part of Sindh pro-
vince of Pakistan, after getting prior approval from Insti-
tutional Review Board (Quaid-I-Azam U IRB#1-
Biomedical; IORG0002926; IRB00003532), and blood
samples were taken from available affected and unaf-
fected family members and DNA was extracted from
whole blood by following the standard proteinase K/
phenol/chloroform isolation method. Written informed
and photography consents (Translated in local Urdu
language) were obtained from the parents/guardians of
patients participating in this study, which conforms to
Helsinki Declaration and local legislation.
B: Clinical Assessments
Affected family members were evaluated with the help
of standard questionnaire (translated and amended ver-
sion of Wechsler Intelligence Scale in Urdu) for severity
of disease and IQ assessments. Photographs of affected
members were taken with written consent to study and
publish their facial features. Two individuals from two
different loops of the pedigree were selected for cranial
CT scan (IV-10 and IV-14) to screen for abnormal brain
anatomical features. For information on disease onset,
parents were interviewed about the prenatal, perinatal
and neonatal medical history of the proband.
C: Molecular Assessments
(i) Genome-wide scan
Whole Genome scan was performed by using Genechip
Mapping 500K array NspI chip (Affymetrix) for four
affected and 2 unaffected family members and the data
was analyzed using dChip and HomozygosityMapper
software for homozygosity mapping and copy number
analysis [17,18]. After fine mapping the region in com-
plete family data was analyzed with Merlin for two-
point and multipoint LOD score calculations. For this
purpose pedigree was divided in to two loops to over-
come size limitations of the Merlin.
(ii) PCR based deletion break-point mapping
To map the deletion breakpoints, primers were designed
(for both upstream and downstream regions) between
the deleted and intact SNPs identified from the
microarray data, using Primer3 software (version 0.4.0)
[19]. PCR was performed for both sets of primers, and
only those sets (from both the distal and proximal
regions) were selected that lie closest to the deleted
SNPs and showed amplification. PCR was performed
using a forward primer from the distal set and reverse
primer from the proximal set to amplify the junction
fragment. The junction fragment was then sequenced,
and the exact physical co-ordinates were determined
using the BLAT tool of the UCSC Genome Browser to
align the sequence to the genome [20].
Results
Clinical description
The family under examination consisted of six affected
individuals from three different extended branches (Fig-
ure 1) and who suffer from cognitive impairment with
an IQ in the range of severe ID (25-35). Prenatal, peri-
natal and neonatal medical histories of all affected indi-
viduals were normal. Ophthalmological and
otorhinolaryngological findings were also normal. Cra-
nial computed tomography (CT) performed on the
patients from two separate loops did not reveal any
brain dysmorphology or neurologic symptoms (Data not
shown). No facial dysmorphism was observed except for
affected individual IV-10 who had strabismus (Figure 2).
In individual IV-15 cognitive impairment was also
accompanied by a form of muscular dystrophy, so this
individual was not treated as affected for the purposes
of the analysis which was later supported by the homo-
zygosity and CNV data. The clinical information of the
affected individuals (on the basis of questionnaire) is
presented in Table 1.
Molecular studies
(i) Genome-wide Homozygosity mapping and CNV analysis
Genome wide homozygosity mapping revealed homo-
zygosity-by-descent (HBD or autozygosity) among four
affected individuals (IV-11, IV-12, IV-13) on 8p23
(Figure 3) between SNPs rs6989820 and rs2237834,
which delineates a critical region of 12.494 Mb {UCSC
genome Browser, May 2004 (NCBI35/hg17)}. In order
to confirm segregation of the identified HBD region in
the entire family STS markers D8S1781, D8S262,
D8S518, D8S1140, D8S277, D8S351, D8S1469, D8S1721,
D8S550, D8S552, D8S1106, D8S1790, D8S1731,
D8S1145 and D8S298 were genotyped. Haplotypes were
generated and are presented in Figure 1, which also
indicate the segregation of a minimum critical region
flanked by above mentioned SNPs. Linkage analysis
yielded two-point and multipoint LOD scores above 3
and 5 respectively at several markers (Table 2). This
region contained a total of 96 known genes {UCSC Gen-
ome Browser, May 2004 (NCBI35/hg17)} including
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to be involved in microcephaly with ID. Initially
MCPH1 gene was sequenced to detect pathogenic muta-
tion in this family but the sequence analysis only
revealed the presence of known SNPs in exon 1
(rs2305023), 6 (rs2442513) and 8 (rs930557 and
rs2920676). Subsequent CNV analysis of microarray
data showed homozygous deletion of 170.673 Kb region
in all affected individuals. The deletion encompassed
almost the entire TUSC3 gene (minus the promoter and
first exon) and its downstream region.
(ii) Deletion breakpoint mapping
The CNV analysis of microarray data revealed that in all
affected individuals no hybridization signals were gener-
ated for 22 SNPs on chromosome 8; from rs4258002 to
rs352769 as borderline deleted SNPs. With the evidence
of microarray data of four affected individuals, size of
deletion fragment was mapped by PCR amplification
Figure 1 Pedigree of a Pakistani family segregating AR-NSID. Square represent male and circles female while black symbols represents
affected individuals and clear symbols unaffected individuals. Autozygosity mapping was done for individuals IV-11, IV-12, IV-13 and IV-14. All
affected individuals share a homozygous haplotype in the chromosome 8p23.1 region, which is shown in boxes. Markers with physical map
distances are shown on the left side.
Figure 2 Facial pictures of patients with front and side pose;
Individual IV-10 has a minor ophthalmic issue, whereas
individuals IV-11, and IV-14 reveal no apparent dysmorphism.
Khan et al. BMC Medical Genetics 2011, 12:56
http://www.biomedcentral.com/1471-2350/12/56
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mer (forward primer 5 ‘-TGCTCTCTGCTCTTCCTC
GT-3’; reverse primer: 5’-CTTTCCTGGCAAGCTGCT
AC-3’) between deleted and intact SNPs (between
rs10094375 and rs4258002 towards the distal end, and
rs352769 and rs6530906 proximally). The BLAT search
for the junction fragment sequence against human gen-
ome revealed the actual physical co-ordinates of deletion
as being between 15521688 bp to 15692362 bp, and
spanning a region of 170.673 Kb. The deletion was also
checked in all available family members by using
TUSC3 exon 3 and 5 and junction fragment primers.
Both of these primer sets showed amplification in the
normal individuals which represented the heterozygous
segregation of this deletion except in individual IV-15.
All the affected individuals of this family were homozy-
gous for the deletion, and no homozygous or heterozy-
gous deletion carriers were identified among 276
unrelated healthy Pakistani individuals. This deletion
encompassed almost the entire TUSC3 gene (minus the
promoter and first exon) and its downstream region
(Figure 4). According to the database of genomics var-
iants [21] 57 CNVs have been reported in HBD region
identified in this family, but 27 involve TUSC3 gene.
The detailed analysis of the CNV data indicates that all
Table 1 Summary of the clinical data of affected individuals
Clinical Findings IV-12 IV-14 IV-13 IV-6 IV-10 IV-11
Sex Female Female Female Male Male Male
Age on assessment 15 years 10 years 13 years 18 years 10 years 11 years
Developmental delay + + + + + +
Head Circumference 52 51 cm 51 Not Available 52 cm 50 cm
Speech Development + + + + + +
Dysmorphic feature - - - - - -
Skeletal Problem - - - - - -
Ophthalmological problem - - - - - -
Epilepsy - + - - - -
Mental retardation Severe Severe Severe Severe Severe Severe
Growth Normal Normal Weak Normal Normal Normal
Schooling - - - - - -
Learning Disability + + + + + +
Muscular dystrophy - - - - - -
Self biting - - - - - -
Each column indicates the data of an individual and row presents the category of clinical symptoms, (- indicates absence, + indicates presence).
Figure 3 Graphical representation of the homozygous by
decent (HBD) regions identified by homozygosity mapper. The
red bar indicates the HBD identified on chromosome 8.
Table 2 Two point and multipoint LOD score between
identified HBD and chromosome 8 markers
Markers Genetic
Position in cM
(Rutgers map,
build 36)
Physical Position
in bp {Feb.2009
(GRCh37/hg19}
Two
point
LOD
Score
Multipoint
LOD Score
D8S1781 6.8 3678400 2.2342 4.2286
D8S262 7.13 3777275 1.0814 4.2143
D8S518 9.88 4587958 0.5706 1.456
rs6989820 - 5041417 -3.8284 -4.0196
D8S1140 11.96 5617059 3.1114 2.9368
D8S277 14.92 6616946 2.9565 5.0000
D8S351 18.94 8877155 3.0286 5.1617
D8S1469 19.38 9090104 1.523 5.1693
D8S1721 19.7 10240822 1.8241 5.1717
D8S550 20.85 10981913 -
Infinity
- Infinity
D8S552 24.76 12842458 2.9823 5.1646
D8S1106 24.76 12936149 3.2113 5.1646
D8S1790 26.35 13166462 3.2843 5.1229
D8S1731 27.95 15338590 1.3825 4.5748
rs2237834 - 17479493 -3.8284 -4.4686
D8S1145 32.78 18452816 -
Infinity
- Infinity
D8S298 40.11 21862145 -
Infinity
- Infinity
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heterozygous state.
Discussion and Conclusion
Autosomal recessive NSID accounts for ~25% of genetic
ID cases and may be more common than X linked
cases, however, the molecular basis of AR-NSID is rela-
tively poorly known because of clinical and genetic het-
erogeneity, and the absence of distinguishing clinical
criteria. In non-syndromic ID, cognitive deficit is the
sole clinical feature among the patients. It is suggested
that ID may be caused by the disruption of the biologi-
cal and molecular processes in the nervous system such
as neuronal differentiation and synaptic plasticity, synap-
tic vesicles cycling and gene expression, regulation pro-
filing etc [22]. There are number of co-translational and
post-translational modifications required for protein sta-
bility and proper protein folding into its 3D structure,
which are essential for normal protein function. One
such post-translational modification, N-glycosylation,
has previously reported to be involved in non-syndromic
X-linked ID at a TUSC3 paralogous gene, IAP [9].
I nt h ec u r r e n ts t u d yw ea n a l y z e daf o u rg e n e r a t i o n
Pakistani family with 6 affected individuals having severe
psychomotor developmental delay, segregating autoso-
mal recessive mode of inheritance. The major clinical
presentations of all patients were normal except for the
cognitive dysfunction. However comparison of the clini-
cal data (Biometric and neurological data) of our family
with the patients of earlier reports did not reveal any
significant difference in the phenotypic expression
[9,10]. TUSC3 is the 5
th gene in autosomal recessive
NSID and the 2
nd in which a 3
rd mutation has been
identified, after TRAPPC9. Our study will aid in diag-
nostic assessment of AR-NSID individuals.
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